Greenwich LifeSciences Inc
At close: Feb 20
After Hours: 5:54PM EDT
Vol / Avg.90.739K / 25.974KMkt Cap169.596M
Day Range11.400 - 13.44052 Wk Range7.580 - 17.230

Greenwich LifeSciences Stock (NASDAQ:GLSI), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1


Highest Price Target1


Lowest Price Target1


Consensus Price Target1


Analyst Rating Summary1


Analyst Firms Making Recommendations1

  • HC Wainwright & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Greenwich LifeSciences

Buy Now
Current price
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/20/2024GLSIBuy Now
Greenwich LifeSciences
$13.20172.73%HC Wainwright & Co.
Yi Chen
$38 → $36MaintainsBuyGet Alert
04/10/2023GLSIBuy Now
Greenwich LifeSciences
$13.20187.88%HC Wainwright & Co.
Yi Chen
$78 → $38Reiterates → BuyGet Alert
09/01/2021GLSIBuy Now
Greenwich LifeSciences
$13.20490.91%HC Wainwright & Co.
Yi Chen
Initiates → BuyGet Alert

What is the target price for Greenwich LifeSciences (GLSI)?


The latest price target for Greenwich LifeSciences (NASDAQ: GLSI) was reported by HC Wainwright & Co. on February 20, 2024. The analyst firm set a price target for $36.00 expecting GLSI to rise to within 12 months (a possible 172.73% upside). 2 analyst firms have reported ratings in the last year.


What is the most recent analyst rating for Greenwich LifeSciences (GLSI)?


The latest analyst rating for Greenwich LifeSciences (NASDAQ: GLSI) was provided by HC Wainwright & Co., and Greenwich LifeSciences maintained their buy rating.


When is the next analyst rating going to be posted or updated for Greenwich LifeSciences (GLSI)?


Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Greenwich LifeSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Greenwich LifeSciences was filed on February 20, 2024 so you should expect the next rating to be made available sometime around February 20, 2025.


Is the Analyst Rating Greenwich LifeSciences (GLSI) correct?


While ratings are subjective and will change, the latest Greenwich LifeSciences (GLSI) rating was a maintained with a price target of $38.00 to $36.00. The current price Greenwich LifeSciences (GLSI) is trading at is $13.20, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.